Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Advanced Prostate Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

Journal Scan / Research · May 10, 2022

Clinical and Pathological Features Associated With Circulating Tumor DNA in Patients With Metastatic PCa

The Prostate


Additional Info

The Prostate
Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer
Prostate 2022 May 01;82(7)867-875, ES Antonarakis, M Tierno, V Fisher, H Tukachinsky, S Alexander, O Hamdani, MC Hiemenz, RSP Huang, GR Oxnard, RP Graf

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading